ReWalk Robotics Ltd. (RWLK)
After hours:
- GlobeNewswire
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs
Paralyzed individuals with spinal cord injury will have unprecedented access to walking in everyday environments as they are no longer limited when encountering stairs and curbs ReWalk Users Now Able to Access Stairs and Curbs in the US A paralyzed individual walks up the stairs to visit a friend's home using her ReWalk Personal Exoskeleton. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”),
- Simply Wall St.
ReWalk Robotics Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
ReWalk Robotics ( NASDAQ:RWLK ) Full Year 2022 Results Key Financial Results Net loss: US$19.6m (loss widened by 54...
- Zacks
ReWalk Robotics (RWLK) Reports Q4 Loss, Tops Revenue Estimates
ReWalk (RWLK) delivered earnings and revenue surprises of -28.57% and 3.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
